Oncology Drugs Market Research Report, Growth & Forecast

... Breast Cancer Drug Market. US breast cancer drug market has high potency of growth with 42 drugs being commercially available and more than 300 of them being in the clinical pipeline ... . It is definitive that the market will grow due to the increase in prevalence of breast cancer and large ...

... Drug Market Overview Dosage, Price & Patent Insight Global Malignant Melanoma Drug Clinical Pipeline: 197 Drugs Marketed Malignant Melanoma Drug Clinical Insight: 25 Drugs Sales Analysis of Global Melanoma Therapeutics Regional Analysis of the Melanoma Drug Market Melanoma occurs due to mutations in the skin ...

... Drugs Market Analysis of Diffuse Large B Cell Lymphoma Market Sales Opportunity till 2024 Global Diffuse Large B Cell Lymphoma Clinical Pipeline: 84 Drugs Marketed Global Diffuse Large B Cell Lymphoma Clinical Insight Hematological Cancers are the most fatal types of cancer as they affect the blood cells ...

... of Radioimmunotherapy Clinical Status of Radioimmunotherapy in Various Cancer Therapy Emerging Opportunities in the Radioimmunotherapy Segment Patent, Dosage & Price Analysis Antibodies in Radioimmunotherapy Global Radioimmunotherapy Clinical Pipeline: 68 Drugs Clinical Pipeline analysis by Phase Cancer ...

... . Metastatic cancer therapy market is further segmented into each type of metastatic cancer such as lung cancer, breast cancer, prostate cancer, brain tumor and several others which are the most common types of cancers globally ...

... analysis of 10 cancer tubulin inhibitors commercially available in the market. “Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024” Report highlights: Clinical Insight on 70 Tubulin Inhibitors in pipeline Dosage & Price Analysis of 10 Commercialized Drugs Patent ...

... 45 CDK inhibitors are in various phases of clinical pipeline. “Global Cancer CDK Inhibitors Market & Clinical Pipeline Outlook 2022” report highlights: Selectivity & Working Mechanism of a Cancer CDKs Inhibitor Recent Advances in the CDKs Related Cancer Therapy Global Cancer CDK Inhibitors Clinical Trials ...

... Cancer Janus Kinase Inhibitors Market Opportunity & Clinical Trial Insight 2023” Highlights: Mechanism of Action of JAK/STAT Inhibitors Global Cancer JAK/STAT Inhibitor Market Outlook Global JAK/STAT Inhibitor Market Opportunity: US$ 4 Billion Global JAK/STAT Inhibitor in Pipeline: 27 Drugs Global Cancer JAK ...

... cancer cells. “CD Antigen Cancer Therapy Market Outlook & Clinical Trials Insight 2023” report highlights: Market Opportunity Assessment: More than US$ 60 Billion by 2023 Clinical & Patent Insight on 17 Commercialize CD Antigen Drugs Clinical & Licensing Insight on 184 CD Antigens in Clinical ...

The Global Breast Cancer Therapeutics Market was valued at USD 31.5 billion in 2024 and is estimated to grow at a CAGR of 8.5% to reach USD 71.3 billion by 2034. The market growth is attributed to a c...

... photodynamic therapy market. “Global Cancer Photodynamic Therapy Market & Cancer Photosensitisers Clinical Trial Outlook 2023” Report Highlight: Working Mechanism of the Photodynamic Cancer Therapy Photosensitizer Delivery Anti-Tumor Activity of the Photodynamic Therapy Status of Various Cancer Treatments ...

... Antibody Drug Conjugates Market & Clinical Pipeline Insight 2022” report highlights: Impetus of Antibody Drug Conjugates Mechanism of Cancer Antibody Drug Conjugates Global Cancer Antibody Drug Conjugate Clinical Pipeline Overview Marketed Cancer Antibody Drug Conjugate Clinical Insight Global Cancer Antibody ...

... cancer vaccine, 44 Cancer monoclonal antibodies, 3 cancer cell therapies and 61 cancer Immunomodulators are commercially available in the market. Pharmaceutical companies are actively engaged in research and development of cancer immunotherapies ...

... immune checkpoint inhibitors in the market. “Global Immune Check Point Inhibitors Market & Clinical Pipeline Insight 2022” report highlights: Introduction & Mechanism of Action of Immune Checkpoint Inhibitors CTLA 4, PD-1 & PD-L1 Inhibition Approved Drugs to Target Immune Checkpoints ...

... Cancer Tyrosine Kinase Inhibitors Signaling Pathway of Receptor Tyrosine Kinase Advantage of Tyrosine Kinase Inhibitors for Treatment of Cancer Applications of Tyrosine Kinase Inhibitor in Cancer Therapy Global Tyrosine Kinase Inhibitors Market Overview Global Cancer Tyrosine Kinase Inhibitors ...

... Angiogenesis Inhibitors Metronomic Therapy - A Recent Advancement in Anti-Angiogenesis Therapy Global Cancer Angiogenesis Inhibitors Clinical Pipeline by Company, Indication & Phase Global Cancer Angiogenesis Inhibitors Clinical Pipeline: 146 Drugs Marketed Cancer Angiogenesis Inhibitors Drugs: 11 Drugs ...

... Immunotoxins to Multiple Cancer Therapies Global Cancer Immunotoxins Market Future Prospects Global Cancer Immunotoxins Clinical Pipeline by Company, Indication & Phase Global Cancer Immunotoxins Clinical Pipeline: 52 Cancer Immunotoxins Majority Cancer Immunotoxins ...

... Global Malignant Melanoma Drug Market & Clinical Pipeline Insight” Report Highlight: Global Malignant Melanoma Market Analysis Malignant Melanoma Drug Mechanism of Action Global Malignant Melanoma Clinical Pipeline By Company & Phase Global Malignant Melanoma Clinical Pipeline: 201 Drugs Majority Malignant ...

... Cancer CD Antigens Inhibitors Therapy Market & Pipeline Insight 2015” Report Highlight: Nomenclature & Classification of CD Antigens Mechanism of CD Antigen Cancer Therapeutics Cancer CD Antigen Therapy Market Overview Cancer CD Antigen Inhibitors Clinical Pipeline by Company, Indication & Phase Cancer ...

... Breast Cancer Incidence & Prevalence US Breast Cancer Therapy Market Overview US Breast Cancer Drug Clinical Pipeline by Company & Phase US Breast Cancer Drug Clinical Pipeline: 251 Drugs Majority Drugs in Phase-II Trials: 73 Drugs Marketed Breast Cancer Drugs in US: 32 Drugs Breast Cancer ...

... & Prevalence Blood Cancer Drug Market Overview Blood Cancer Drug Market Dynamics Leukemia, Lymphoma & Myeloma Drug Clinical Pipeline Insight Leukemia, Lymphoma & Myeloma Drug Clinical Pipeline: 435 Drugs Majority Drugs in Phase-I Clinical Trials: 128 Drugs Marketed Leukemia, Lymphoma & Myeloma Drug Clinical ...

... Monoclonal Antibodies, Vaccines 'Global Cancer Immunotherapy Market Outlook 2020' Report Highlight: Introduction & Classification of Cancer Immunotherapy Global Cancer Immunotherapy Pipeline by Company, Indication & Phase Marketed Cancer Immunotherapies ...

... Oncogene Inhibitors Pipeline: 185 Drugs Majority Oncogene Inhibitors in Preclinical Phase: 105 Drugs Proto Oncogene Protein c met Inhibitors Pipeline: 42 Drugs Proto Oncogene Protein c-akt Inhibitors: 39 Drugs Marketed Oncogene Inhibitors: 22 Drugs Marketed Proto-Oncogene Protein c-bcl-2 Inhibitors: 8 Drugs ...

... Tyrosine Kinase Therapeutics Global Tyrosine Kinase Inhibitors Pipeline by Company, Indication & Phase Global Tyrosine Kinase Inhibitors Pipeline: 557 Drugs Majority Drugs in Preclinical Phase: 239 Drugs Marketed Tyrosine Kinase Inhibitors: 58 Drugs Marketed Tyrosine Kinase Inhibitors ...

... Cancer Targeted Therapy Market & Clinical Insight” Report Highlight: Introduction & Categorization of Cancer Targeted Therapies Mechanism of Cancer Targeted Tyrosine Kinase, Vaccines, Oncogenes Inhibitors, Monoclonal Antibodies Cancer Targeted Therapy ...

... Cancer Growth Inhibitors Cancer Growth Inhibitors Clinical Pipeline by Company, Indication & Phase Cancer Growth Inhibitors Clinical Pipeline: 629 Drugs Markets Cancer Growth Inhibitors: 48 Drugs Tyrosine Kinase Dominates Cancer Growth Inhibitors Pipeline: 394 Drugs HDAC Inhibitors Clinical Pipeline: 65 Drugs ...

... Non Small Cell Lung Cancer Market & Pipeline Insight” Report Highlights: NSCLC Therapy Market Overview Mechanism of NSCLC Therapeutics NSCLC Therapy Market Dynamics: Drivers, Challenges & Future Prospects) NSCLC Drug Pipeline ...

... Non Hodgkin Lymphoma therapeutics. “Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight” Report Highlight: Global Non Hodgkin Lymphoma Market Overview Mechanism of Non Hodgkin Lymphoma Therapeutics Global Non Hodgkin Lymphoma Pipeline by Type, Phase & Company Global Non Hodgkin Lymphoma Pipeline ...

... Cancer Monoclonal Antibodies Pipeline by Phase, Indication, Company & Country Cancer Monoclonal Antibodies in Pipeline: 605 Majority Cancer Monoclonal Antibodies Preclinical Phase: 258 Marketed Cancer Monoclonal Antibodies: 34 Cancer Monoclonal Antibodies ...

... Global Cancer Kinase Inhibitors Market & Pipeline Insight” Report Highlight: Classification & Mechanism of Kinase Inhibitors Cancer Kinase Inhibitors Therapy Market Overview Cancer Kinase Inhibitors Therapy Pipeline by Phase, Indication, Company & Country Marketed Cancer Kinase Inhibitors Therapy ...

... use. “Cancer Immunotherapy Market & Clinical Pipeline Insight” Report Highlights: Cancer Immunotherapy Market Overview Cancer Immunotherapy Market Dynamics Cancer Immunotherapy Pipeline: 1080 Drug in Clinical Pipeline Cancer Monoclonal Antibodies Clinical Pipeline by Phase & Country Cancer Vaccine Clinical ...